CHF 5074

DRUG2 trials

Sponsors

CERESPIR

Conditions

Alzheimer's Disease

Phase 1

Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects

CompletedNCT00954252

CERESPIRAlzheimer's Disease

Start: 2009-10-31End: 2010-05-31Updated: 2015-02-10

Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects

CompletedNCT01258452

CERESPIRAlzheimer's Disease

Start: 2011-02-28End: 2011-03-31Updated: 2015-02-10